Table 3.
Demographics and comparison of treatment outcomes in patients pursuing assisted reproduction before versus after their cancer treatment
| Before treatment group (n = 12) | After treatment group (n = 19) | P value | |
|---|---|---|---|
| Age at cycle start (y) | 30 ± 4 | 33 ± 6 | NS |
| Day 2 serum FSH (IU/L) | 5 ± 3 | 7 ± 4 | NS |
| Day 2 serum estradiol (pg/ml) | 46 ± 20 | 36 ± 15 | NS |
| Partnership status | 7 single/5 married | 8 single/9 married/2 significant other | – |
| Time: RE consult to FP treatment (days) | 12 (range 4–49) | 14 (range 0–176) | – |
| Time: RE consult to oocyte harvest (days) | 25 (range 15–60) | 31 (range 9–196) | – |
| Total gonadotropins used (IU) | 3592 ± 828 | 3572 ± 1355 | NS |
| Maximum serum estradiol (pg/ml) | 2634 ± 1277 | 1875 ± 1752 | NS |
| No. oocytes retrieved | 23 ± 10 | 11 ± 10 | 0.003 |
| No. frozen gametes (egg/embryo) | 17 ± 11 | 8 ± 9 | 0.03 |
| Cycles canceled for poor response | 0 | 5 | – |